Table 5.

A summary of the dosimetric parameters for ${\mathbb{P}}^{\text{WH}}$, ${\mathbb{P}}^{\text{WF}}$ and ${\mathbb{P}}^{\text{RF}}$ plans for a single patient

Parameter	Whole gland homogeneous (${\mathbb{P}}^{\text{WH}}$)	Whole gland with focal boost (${\mathbb{P}}^{\text{WF}}$)	Focal (${\mathbb{P}}^{\text{RF}}$)	(${\mathbb{P}}^{\text{WF}}-{\mathbb{P}}^{\text{WH}}$)	(${\mathbb{P}}^{\text{RF}}-{\mathbb{P}}^{\text{WH}}$)
Prostate
V 100 %	99.6	99.32	94.21	-0.28	-5.39
D 98 Gy.	80.2	79.6	85.2	-0.6	5
D min (0.03 cc.) Gy.	76.7	78.5	83.8	1.8	7.1
D max(0.03 cc.) Gy.	81.9	102.5	91.3	20.6	9.4
Mean Dose Gy.	80.8	84.09	87.9	3.29	7.1
Bladder
V 15% Gy.	60.7	65.5	1.45	4.8	-59.25
V 25% Gy.	46.9	51.7	1.85	4.8	-45.05
V 35% Gy.	36.1	42.6	1.67	6.5	-34.43
V 50% Gy.	24.1	33	1.45	8.9	-22.65
Rectum
V 15% Gy.	63.7	60	10.5	-3.7	-53.2
V 25% Gy.	50.8	50.2	4.35	-0.6	-46.45
V 35% Gy.	36.5	42.8	2.65	6.3	-33.85
V 50% Gy.	23.2	27	1.9	3.8	-21.3
Penile bulb
Mean Dose Gy.	48.98	61.97	3.65	12.99	-45.33
L. Femoral Head
Mean Dose Gy.	22.1	23.3	2.3	1.2	-19.8
R. Femoral Head
Mean Dose Gy.	19.8	21.3	1.4	1.5	-18.4

It can be observed that the ${\mathbb{P}}^{\text{RF}}$ resulted in significant reduction in the dosage to surrounding regions including bladder, rectum, penile bulb and the femoral heads (highlighted in bold-face)